The Phacilitate Cell & Gene Therapy Forum provides an annual meeting place for senior level figures driving the transition of these technologies into safe, commercially viable products. The event gives technology companies, big pharma and biotech, the regulators and the investment community an unparalleled chance to exchange opinions and to network in exclusive, yet informal surroundings. The program features a stimulating blend of plenary sessions addressing key strategic challenges and breakout sessions promoting in-depth discussion of major business, regulatory and scientific issues. This format allows you to select between issues common to both cell and gene-based therapies and those specific to one or the other. The event runs concurrently with the Phacilitate Vaccine Forum Washington 2008.
Explore
Membership
